Oxis about to price flotation in France:
This article was originally published in Clinica
Executive Summary
Oxis International, a US drug discovery and diagnostics company, plans to float on the French stock exchange, Nouveau Marche, later this month. It aims to sell around 11 million shares pricing them at the end of April. Oxis, based in Portland, Oregon, is already quoted on the US Nasdaq and will become the first Nasdaq-quoted company traded on Nouveau Marche, an exchange for emerging growth companies.